On World Cancer Day, what’s wrong with a bit of Neuroendocrine Cancer awareness? Well, there are three main things wrong with Neuroendocrine Cancer awareness:
If the community does not address these 3 issues, awareness will continue to fail and continue to flounder. I standby to help with the change, in fact, my work started in 2015 and continues.
1. To be told your cancer isn’t really cancer is an insult.
2. To be called an animal is to be dehumanised.
3. To be rare when you’re not, is a step back and is hindering access to clinical trial research.
WE NEED A NEW PARADIGM.
First thing wrong

The community remains entrenched in 1907 terminology which needs to be brought into 2021. Things have moved on so much but the use of this ancient terminology and what it infers, just keeps us marking time in the last century. It does not do us any favours in awareness terms, nor does it do us any favours in clinical terms. If clinicians, scientific organisations (including pharma), and patient advocate organisations will not move on, we as patients and advocates need to pull them along with us. We need to do all we can to remove the term “Carcinoid” from our vocabulary. Read more on this issue by clicking here or on the picture:
Second thing wrong
When an outsider looks into the Neuroendocrine Cancer community, it shouldn’t be a surprise if their first thoughts were that it was some sort of animal welfare or zoological group, particularly focused on black and white striped animals. Unfortunately, on this issue, the community seems to be so infatuated by the subject, that it’s blinkered to the abject failure of this marketing gimmick and it’s more of a cult than a community. Like the 1907 parlance above, we also need to move away from this cult thing. Maybe we should employ marketeers in our international awareness activities and if we currently do, then we need another set ASAP. Read more here or click on the picture:

Third thing wrong

Finally, and I guess this is related to both of the issues above, more with the animal stuff than the nomenclature issue, the incidence and prevalence of Neuroendocrine Neoplasms (the combination of Neuroendocrine Tumours (NET) and Neuroendocrine Carcinomas (NEC)) have skyrocketed in the last 40 years to the point that many scientists, epidemiologists and Neuroendocrine specialists are starting to use different terminology, commensurate with the math. Read more by clicking here or on the picture below.
Let’s do the math not the myth.
Disclaimer
I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or advised by me.
Neither should any post or comment made by a follower or member of my private group be assumed to be medical advice, even if that person is a healthcare professional. Some content may be generated by AI which can sometimes be misinterpreted. Please check any references attached.
Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the counter drugs and supplements such as vitamins and minerals.
Click here and answer all questions to join my private Facebook group
Facebook
Twitter
WordPress
Instagram
Thanks for reading.
Check out my Glossary of Terms – click here
Please Share this post for Neuroendocrine Cancer awareness and to help another patient
Neuroendocrine Cancer – normally slow but always sneaky – an awareness post from Ronny AllanOctober 30, 2017
Clinical Trial: Survivin Long Peptide Vaccine (SurVaxM) in Treating Patients With Metastatic Neuroendocrine TumorsMay 22, 2021Discover more from Ronny Allan - Living with Neuroendocrine Cancer
Subscribe to get the latest posts sent to your email.











I am in total agreement. Terminology must change so patients with NETs understand this disease is not rare. NETs is not as common as some other cancers and can be tricky to diagnose. Of course, there is a process of elimination through various tests and procedures. But thinking in terminology taught in medical schools must change.
My husband, a practicing radiologist until his death last month, lived by the zebra code. OLD SCHOOL! We must use proper language to describe common, not so common and uncommon medical conditions. Patients need to educated, not insulted.
thanks, I often feel alone in this thinking. I know I’m not but more people within the community need to speak up and not be frightened to challenge.